Literature DB >> 9007740

Reversible dementia in elderly patients referred to a memory clinic.

G J Walstra1, S Teunisse, W A van Gool, H van Crevel.   

Abstract

Dementia has a reversible cause in some cases, and these should be diagnosed without over-investigating the many patients with irreversible disease. We prospectively studied the prevalence of reversible dementia in a memory clinic, determined the added value of investigations compared with clinical examination and assessed the outcome of treatment of potentially reversible causes by measuring (1) cognition, (2) disability in daily functioning, (3) behavioural changes and (4) caregiver burden. Two hundred patients aged 65 years and over were examined, using the CAMDEX-N. If they were demented, the probable cause was diagnosed clinically and confirmed or excluded by a standard set of investigations, which were done in all patients. Of the patients, 170 (mean age 79.2 years) were demented; 31 were treated for potentially reversible causes. At follow-up after 6 months, no patients showed complete reversal of dementia. Five patients improved on clinical impression, but only one on clinical measurement. Thirty patients were cognitively impaired, but not demented; seven were treated. Judged clinically, three patients improved, but on assessment only one did so; she recovered completely. Blood tests often produced diagnostic results that were not expected clinically, but electroencephalography and computed tomography of the brain did not. None of the investigations had an effect on outcome of dementia after treatment. We conclude that in elderly patients referred to a memory clinic, the prevalence of reversible dementia is of the order of 1%, if outcome after treatment is assessed by a standardized measurement. We recommend blood tests in all patients, to detect not only metabolic causes of dementia but also co-morbidity possibly worsening the dementia. Other investigations can be performed on clinical indication. Clinical evaluation remains the mainstay of diagnosis in dementia.

Entities:  

Mesh:

Year:  1997        PMID: 9007740     DOI: 10.1007/pl00007724

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Individualized evaluation of cholinesterase inhibitors effects in dementia with adaptive cognitive testing.

Authors:  Hans Wouters; Jos P C M Van Campen; Bregje A Appels; Jos H Beijnen; Aeilko H Zwinderman; Willem A Van Gool; Ben Schmand
Journal:  Int J Methods Psychiatr Res       Date:  2015-08-24       Impact factor: 4.035

2.  Potentially reversible conditions in 1000 consecutive memory clinic patients.

Authors:  A Hejl; P Høgh; G Waldemar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 3.  Psychological interventions for depression in adolescent and adult congenital heart disease.

Authors:  G Y H Lip; D A Lane; T A Millane; M H Tayebjee
Journal:  Cochrane Database Syst Rev       Date:  2003

4.  Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort.

Authors:  S Freter; H Bergman; S Gold; H Chertkow; A M Clarfield
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

5.  Does MRI Increase the Diagnostic Confidence of Physicians in an Outpatient Memory Clinic.

Authors:  Leo Boelaarts; Philip Scheltens; Jos de Jonghe
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-06-25

6.  Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study.

Authors:  Suman Kushwaha; Puneet Talwar; Aldrin Anthony; Meena Gupta; Kiran Bala; Rachna Agarwal; Vibha Sharma; Ritushree Kukreti
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-07-26

7.  Dementia Improvement after Plasma Exchange for Familial Hypercholesterolemia.

Authors:  Allen J Orehek
Journal:  Case Rep Neurol Med       Date:  2016-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.